PIK3CA and colorectal carcinoma: This group demonstrated that BMP7 exerts potent antitumour activity by inducing the differentiation of PIK3CA wild-type CRC stem cells (wt CR-CSCs) and suggested that BMP7-based combination therapies may represent potential novel treatment options for CRC.